目前,随着科技的进步和经济的发展,全球面临着维持血液透析人群迅速增长的趋势。透析人群已从1990年42万6千人增长至2000年的106万5千人,预计2010年将达到200万人。心血管疾病(Cardiovascular diseases,CVD)是慢性维持血液透析(MHD)患者的主要并发症,也是维持性血液透析患者首位的死亡原因。据统计,欧美国家终末期肾衰竭(ESRD)接受透析治疗患者因心血管并发症死亡的占50％以上,其中最多的是心肌梗死、心包炎、充血性心力衰竭和心律失常等。 At present, with the progress of science and technology and economic development, the global community is facing the trend of maintaining the rapid growth of hemodialysis patients. The dialysis population has risen from 426,000 in 1990 to 1,065,000 in 2000 and is expected to reach 2 million in 2010. Cardiovascular diseases (CVD) are a major complication of chronic maintenance hemodialysis (MHD) and are the leading cause of death in maintenance hemodialysis patients. According to statistics, in European and American countries, patients with end-stage renal failure (ESRD) undergoing dialysis account for over 50% of deaths from cardiovascular complications, most of which are myocardial infarction, pericarditis, congestive heart failure and arrhythmia.